Top Markets
Coin of the day
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
Rang in aandelen #33745
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Aandeelprijs
$0.11637199
Marktkapitalisatie
$7.20M
Verandering (1 dag)
3.13%
Verandering (1 jaar)
171.06%
Land
AU
Handel Vectus Biosystems Limited (VBS)

Categorie

Koersgeschiedenis voor Vectus Biosystems Limited (VBS)
Hoogste slotkoers: $0.11 op 2026-08-01

Laagste slotkoers: $1.09 op 2016-02-01
Koersgeschiedenis van Vectus Biosystems Limited van 2016 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -0.53%
2025 89.66%
2024 -76.86%
2023 -62.94%
2022 -37.77%
2021 -3.80%
2020 134.91%
2019 -5.17%
2018 -59.48%
2017 -8.31%
2016 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE